Representative Thomas Kean Jr., a New Jersey Republican who has been absent from Congress for nearly three months due to an undisclosed medical condition, disclosed a purchase of Texas Instruments ($TXN) stock made during his disappearance from public view. The April 14 trade, valued between $1,001 and $15,000, was the only purchase listed on the filing while several other holdings were sold or partially sold. Shares of Texas Instruments have since risen roughly 45% from the time of the trade.
- Kean disclosed the transaction on May 22 through the Kean Family Partnership, according to congressional filings.
- Kean serves on the House Energy and Commerce Committee, including the Communications and Technology and Commerce, Manufacturing and Trade subcommittees.
- Texas Instruments has rallied in recent months amid strong semiconductor and AI infrastructure demand.
- Corporate lobbying disclosures show Texas Instruments has spent millions lobbying on semiconductor manufacturing, trade policy, communications infrastructure, tax issues, and domestic supply chain legislation in recent years.
- Kean’s office recently said he expects to return to voting and campaigning in the coming weeks following what aides described only as a “personal medical condition.”
Relevant Companies
- Texas Instruments ($TXN) – The company has benefited from semiconductor and AI infrastructure demand alongside ongoing U.S. manufacturing expansion.
- NVIDIA ($NVDA) – Continued AI infrastructure spending has supported broader semiconductor sector momentum.
- Advanced Micro Devices ($AMD) – AI and data center demand trends continue driving investor interest across chipmakers.
Editor’s Note: This is a developing story. This article may be updated as more details become available.
